Skip to main content
Clinical Trials/CTRI/2025/05/086318
CTRI/2025/05/086318RecruitingPhase 2/3

An Open-Label Add-On Randomized Controlled Trial to Assess the Efficacy of Deep Tissue Heating as an Adjuvant Therapy in Patients with Severe Diabetic Foot Ulcers

College of Medicine and Sagore Dutta Hospital1 site in 1 country50 target enrollmentStarted: May 19, 2025Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Recruiting
Sponsor
Enrollment
50
Locations
1
Primary Endpoint
Improved healing rate, healing time, infection rate, amputation rate.

Study Overview

Brief Summary

The standard treatment guidelines for the prevention and management of diabetic foot include conventional treatments such as infection management and surgical interventions. Improvement of blood blow rates in the affected peripheral tissues of the body improves the accessibility of drugs and tissue repair proteins and potentially reduces the wound healing time. This adjuvant therapy would potentially provide a faster therapeutic solution for DFUs.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 80.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Individuals with diabetic foot ulcers.

Exclusion Criteria

  • Individuals with severe comorbidities.

Outcomes

Primary Outcomes

Improved healing rate, healing time, infection rate, amputation rate.

Time Frame: Weekly monitoring from baseline. Comparison every 4 weeks.

Secondary Outcomes

  • Wound healing rate, infection rate, amputation rate, all cause mortality.(Baseline, 8 Weeks, 6 months.)

Investigators

Sponsor
College of Medicine and Sagore Dutta Hospital
Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Subhasish Sarkar

College of Medicine and Sagore Dutta Hospital

Study Sites (1)

Loading locations...

Similar Trials